Cello Health Plc

Cello Health (CLL)

Company name:Cello Health Plc
EPIC:CLLTrading Currency:GBX
Market Sector:AIMPISIN:GB00B0310763
Market Segment:ASX1Share Type:DE
WWW Address:www.cellohealthplc.comDescription:ORD 10P
Industry Sector:MEDIA
 Price Price Change [%] Bid Offer Open High Low Volume
 131.00 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 130.00 132.00 131.00 131.00 131.00 818
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 138.98 106.09 0.05 6.27 3.85 20.89 2.94 138.50 - 99.50

Cello Health Key Figures

(at previous day's close)
Market Cap.138.98m
Shares In Issue106.09m
Prev. Close131.00
PE Ratio20.89 
Dividend Yield2.94%
EPS - basic6.27p
Dividend PS3.85p
Dividend Cover1.63 
Cash Flow PS10.54p
Return On Equity (ROE)7.62%
Operating Margin5.08%
PEG Factor0.39 
EPS Growth Rate53.30%
Dividends PS Growth Rate10.00%
Net Debt40.48m
Gross Gearing36.96%
Quick Assets59.80m
Net Working Capital14.40m
Intangibles / Fixed Assets96.24%
Turnover PS156.07p
Pre-Tax Profit PS7.94p
Retained Profit PS2.74p
Cash PS9.83p
Net Cash PS-32.96p
Net Tangible Asset Value PS *11.14p
Net Asset Value PS81.85p
Spread2.00 (1.52%) 

Cello Health Balance Sheet

LSE:CLL:Liabilities+EQLSE:CLL:Assets

Share Price Performance

Sample Period HighLow
1 week133.50128.00
4 weeks133.50126.00
12 weeks133.50119.00
1 year138.5099.50

Share Price Chart (5 years)

Cello Health Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week131.50-0.50-0.38128.000.03132.12
4 weeks128.502.501.95126.000.22129.32
12 weeks122.009.007.38119.000.13128.20
26 weeks134.00-3.00-2.24110.000.13126.00
1 year100.5030.5030.3599.500.14123.87
3 years102.5028.5027.8095.700.12121.94
5 years84.0047.0055.9578.000.11112.48

Cello Health Key Management Ratios

Cello Health Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio26.41 
PE Ratio20.89 
Tobin's Q Ratio 0.98 
Tobin's Q Ratio (excl. intangibles)2.07 
Dividend Yield2.94%
Market-to-Book Ratio1.60 
Price-to-Pre-Tax Profit PS16.51 
Price-to-Retained Profit PS47.86 
Price-to-Cash Flow PS12.43 
Price-to-Sales PS0.84 
Price-to-Net Tangible Asset Value PS11.76 
Price-to-Cash PS13.33 
Net Working Capital PS13.57 
Price Pct to Working Capital PS9.65%
Earnings Yield4.79%
Average PE27.35 
Years in average4 
PE to PE average76.39%

Cello Health Financial Ratios

(Leverage Ratios)
Debt Ratio5.97%
Debt-to-Equity Ratio0.06 
Debt-to-Equity Ratio (excl. Intgbl)0.47 
Debt-to-Equity Market Value0.04 
Net Gearing29.39%
Net Gearing (excl. Intangibles)64.53%
Gross Gearing36.96%
Gross Gearing (excl. Intangibles)81.15%
Gearing Under 1 Year32.96%
Gearing Under 1 Year (excl. Intgbl)72.37%
Assets/Equity1.59 
Cash/Equity12.00 
(Liquidity Ratios)
Net Working Capital to Total Assets10.45%
Current Ratio1.32 
Quick Ratio (Acid Test)1.32 
Liquidity Ratio0.23 
Cash & Equiv/Current Assets17.43%
(Solvency Ratios)
Enterprise Value134.06m
CFO/Sales0.07 
CFO/Attributable Profit1.69 
CFO/Assets0.08 
CFO/Debt0.22 
Total Debt/Equity Market Value0.37 
Total Debt/Sales0.31 
Total Debt/Pre-Tax Profit6.05 
Total Debt50.90m
Total Debt/Net Current Assets3.54%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth18.35%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs7 
Beta (60-Mnth)Beta (36-Mnth)
0.05250.0431

Cello Health Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)9.12%
Return On Assets (ROA)4.67%
Net Profit Margin4.00%
Assets Turnover1.17 
Return On Equity (ROE)7.62%
Return On Investment (ROI)7.04%
Dividend Payout Ratio61.40%
Plowback Ratio38.60%
Growth from Plowback Ratio3.01%
Net Income Of Revenues1.75%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.95 
Fixed Assets Turnover2.14 
Current Assets Turnover2.58 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales0.86 
Debtors-to-Sales31.70%
Debt Collection Period115.70Days

Cello Health Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
21 Mar 2019FinalGBX2.7531/12/201731/12/201825/04/201926/04/201924/05/20193.85
19 Sep 2018InterimGBX1.1031/12/201731/12/201804/10/201805/10/201802/11/2018-
22 Mar 2018FinalGBX2.4531/12/201631/12/201703/05/201804/05/201825/05/20183.50
20 Sep 2017InterimGBX1.0531/12/201631/12/201705/10/201706/10/201703/11/2017-
22 Mar 2017FinalGBX2.4031/12/201531/12/201604/05/201705/05/201726/05/20173.40
14 Sep 2016InterimGBX1.0031/12/201531/12/201606/10/201607/10/201604/11/2016-
17 Mar 2016FinalGBX2.0231/12/201431/12/201505/05/201606/05/201627/05/20162.86
16 Sep 2015InterimGBX0.8431/12/201431/12/201521/10/201522/10/201527/11/2015-
19 Mar 2015FinalGBX1.8031/12/201331/12/201430/04/201501/05/201529/05/20152.60
17 Sep 2014InterimGBX0.8031/12/201331/12/201401/10/201403/10/201407/11/2014-
20 Mar 2014FinalGBX1.6131/12/201231/12/201304/06/201406/06/201404/07/20142.25
18 Sep 2013InterimGBX0.6431/12/201231/12/201304/12/201306/12/201306/01/2014-
13 Mar 2013FinalGBX1.4231/12/201131/12/201229/05/201331/05/201305/07/20132.00
19 Sep 2012InterimGBX0.5831/12/201131/12/201207/12/201209/12/201204/01/2013-
13 Mar 2012FinalGBX1.1731/12/201031/12/201106/06/201208/06/201206/07/20121.72
13 Sep 2011InterimGBX0.5531/12/201031/12/201107/12/201109/12/201106/01/2012-
15 Mar 2011FinalGBX0.9031/12/200931/12/201008/06/201110/06/201108/07/20111.43
14 Sep 2010InterimGBX0.5331/12/200931/12/201006/10/201008/10/201003/11/2010-
16 Mar 2010FinalGBX0.8031/12/200831/12/200919/05/201021/05/201016/06/20101.30
15 Sep 2009InterimGBX0.5030/06/200830/06/200907/10/200909/10/200904/11/2009-
17 Mar 2009FinalGBX0.7531/12/200731/12/200820/05/200922/05/200917/06/20091.25
16 Sep 2008InterimGBX0.5030/06/200730/06/200808/10/200810/10/200805/11/2008-
23 Mar 2008FinalGBX0.7531/12/200631/12/200721/05/200823/05/200818/06/20081.20
20 Mar 2007FinalGBX0.6031/12/200531/12/200623/05/200725/05/200715/06/20071.00
05 Sep 2006InterimGBX0.4030/12/200530/06/200620/09/200622/09/200613/10/2006-

Cello Health Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover157.32100.00%165.27100.00%169.29100.00%165.57100.00%m
pre tax profit4.753.02%-1.69-1.02%5.823.44%8.425.08%m
attributable profit3.041.93%-2.83-1.71%4.232.50%6.624.00%m
retained profit0.800.51%-5.42-3.28%0.650.39%2.901.75%m
eps - basic (p)3.54 -3.23 4.09 6.27 
eps - diluted (p)3.44 -3.23 4.03 6.14 
dividends per share2.86 3.40 3.50 3.85 

Cello Health Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
LSE:CLL:Liabilities+EQLSE:CLL:AssetsLSE:CLL:Liabilities+EQLSE:CLL:AssetsLSE:CLL:Liabilities+EQLSE:CLL:AssetsLSE:CLL:Liabilities+EQLSE:CLL:Assets
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets1.951.54%2.712.11%2.841.95%2.932.13%m
intangibles intangibles74.7259.08%70.5354.97%74.1550.92%75.0154.46%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors44.5635.23%47.6037.10%55.6038.19%49.3735.84%m
cash & securities cash & securities5.254.15%7.475.82%13.028.94%10.427.57%m
TOTAL126.48100%128.30100%145.61100%137.74100%m
LIABILITIES
creditors - short creditors - short44.6835.32%49.1938.34%49.8934.26%45.4032.96%m
creditors - long creditors - long10.998.69%12.569.79%12.858.82%5.514.00%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL55.6744.01%61.7548.13%62.7443.08%50.9036.96%m
EQUITY
ord cap, reserves ord cap, reserves70.7755.95%66.5551.87%82.8756.92%86.8363.04%m
prefs, minorities prefs, minorities0.050.04%--%--%--%m
TOTAL70.8255.99%66.5551.87%82.8756.92%86.8363.04%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Cello Health Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF7.034.852.7311.18m
Pre-Financing CF5.672.59-4.378.98m
Retained CF-0.481.765.87-2.75m

Cello Health Brokers

NameActivityTypeMnemonicCode
Altium Capital LimitedMarket Maker(MMF)Broker/DealerALTIAPCFGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
CLL
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191207 04:52:22